MedPath

Physical Activity, Dietary Intake and Bone Status in 6-12 Years Children

Completed
Conditions
Bone Status
Interventions
Behavioral: Dietary Intake
Behavioral: physical activity level
Registration Number
NCT03695328
Lead Sponsor
Democritus University of Thrace
Brief Summary

Peak bone mass acquisition through childhood and adolescence has been associated with lower risk of osteopenia and osteoporosis in the elderly. The main factors that influence bone mass are the non-modifiable, such as genetics, ethnicity and sex, and the modifiable ones which are nutrition and physical activity or exercise. In the literature are references that demonstrates positive effects of high physical activity, adequate intakes of macro- and micronutrients on bone mass both in adults and in children. Bone mineralization is more adaptive in childrens' growing bones and this is an opportunity for stronger effects by mechanical stimuli during physical activity. The presence of a diet complete of nutrient intakes seems to strengthen the effects of mechanical loads on bone growth and mineralization. The present trial aimed to evaluate the effects of physical activity and nutrition intakes on bone mass in pre-pubertal children.

Detailed Description

The sample of this study was healthy pre-pubertal boys and girls (N=210) who had training age 0-1 years. Data collection included anthropometric measurements, blood sampling, body composition, bone measurements and physical performance measurements. Nutritional intake was recorded for seven consecutive days in order to evaluate nutrient intakes using an appropriate software and habitual physical activity was measured for the same days using accelerometers. Pubertal stage determined by Tanner scale. All measurements were made only once at the beginning of school year.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria
  • were 6-12 years and pre-pubertal
  • were healthy and had no prior bone fractures or related surgical operation
  • their body fat was <30%, e) had no history of growth irregularities
  • were not receiving agents or drugs that affect bone tissue (e.g. Gonadotropin-Releasing Hormone (GnRH) agonists, antiresorptive, bisphosphonates, etc.)
Exclusion Criteria
  • had prior bone fractures or related surgical operation
  • their body fat was >30%
  • had history of growth irregularities
  • were receiving agents or drugs that affect bone tissue (e.g. GnRH agonists, antiresorptive, bisphosphonates, etc.)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
dietary intakeDietary IntakeChildrens' 24th dietary recalls for 7 days analyzed for protein, calcium, vitamin D and phosphorus intake and they categorized according the RDAs above or below them.
physical activity levelphysical activity levelChildren categorized either in the group with moderate to vigorous physical activity or in the group with low physical activity according the accelerometer's measures
Primary Outcome Measures
NameTimeMethod
Whole body bone mineral density1 day (Once)

Measured by Dual-X-ray Absoroptiometry

Cardiovascular endurance1 day (Once)

20m shuttle run test

Body composition1 day (Once)

Measured by Dual-X-ray Absoroptiometry and skinfolds

Muscular strength1 day (Once)

Handgrip strength

Flexibility1 day (Once)

Sit and reach test

Hips bone mineral density1 day (Once)

Measured by Dual-X-ray Absoroptiometry

Whole body mineral content1 day (Once)

Measured by Dual-X-ray Absoroptiometry

Lumbar spine bone mineral content1 day (Once)

Measured by Dual-X-ray Absoroptiometry

Hips bone mineral content1 day (Once)

Measured by Dual-X-ray Absoroptiometry

Lumbar spine bone mineral density1 day (Once)

Measured by Dual-X-ray Absoroptiometry

Secondary Outcome Measures
NameTimeMethod
Serum calcium1 day (Once)

Measured in blood smaples

Sclerostin1 day (Once)

Measured in blood samples with an appropriate kit

Serum vitamin D1 day (Once)

Measured in blood smaples

Pubertal Stage1 day (Once)

Evaluated with Tanner Stage protocol

© Copyright 2025. All Rights Reserved by MedPath